Replies to post #4460 on Viropro, Inc. (VPRO)

[penniesfromheaven1]

VPRO is now connected to SPPI:


Spectrum Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference

Spectrum (NASDAQ:SPPI)
Intraday Stock Chart
Today : Monday 10 January 2011
Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, announced today that an overview of the Company’s business strategy will be given at the 29th Annual J. P. Morgan Healthcare Conference, being held in at the Westin St. Francis hotel in San Francisco, California. The Spectrum Pharmaceuticals presentation is at 12:00 p.m. Pacific Time on Thursday, January 13, 2011 in the California East room.

The live webcast of Spectrum's corporate presentation will be available at http://www.sppirx.com.

About Spectrum Pharmaceuticals, Inc.

Spectrum Pharmaceuticals is a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology. The Company’s strategy is comprised of acquiring, developing and commercializing a broad and diverse pipeline of late-stage clinical and commercial products. The Company markets two oncology drugs, FUSILEV and ZEVALIN and has two drugs, apaziquone and belinostat, in late stage development along with a diversified pipeline of novel drug candidates. The Company has assembled an integrated in-house scientific team, including clinical development, medical research, regulatory affairs, biostatistics and data management, formulation development, and has established a commercial infrastructure for the marketing of its drug products. The Company also leverages the expertise of its worldwide partners to assist in the execution of its strategy. For more information, please visit the Company’s website at